These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11408564)

  • 1. In vivo synergistic interaction of liposome-coencapsulated gentamicin and ceftazidime.
    Schiffelers RM; Storm G; ten Kate MT; Stearne-Cullen LE; den Hollander JG; Verbrugh HA; Bakker-Woudenberg IA
    J Pharmacol Exp Ther; 2001 Jul; 298(1):369-75. PubMed ID: 11408564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic efficacy of liposome-encapsulated gentamicin in rat Klebsiella pneumoniae pneumonia in relation to impaired host defense and low bacterial susceptibility to gentamicin.
    Schiffelers RM; Storm G; ten Kate MT; Bakker-Woudenberg IA
    Antimicrob Agents Chemother; 2001 Feb; 45(2):464-70. PubMed ID: 11158742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of gentamicin or ceftazidime entrapped in liposomes with prolonged blood circulation and enhanced localization in Klebsiella pneumoniae-infected lung tissue.
    Bakker-Woudenberg IA; ten Kate MT; Stearne-Cullen LE; Woodle MC
    J Infect Dis; 1995 Apr; 171(4):938-47. PubMed ID: 7706822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposome-enabled synergistic interaction of antimicrobial agents.
    Schiffelers RM; Storm G; ten Kate MT; Stearne-Cullen LE; den Hollander JG; Verbrugh HA; Bakker-Woudenberg IA
    J Liposome Res; 2002; 12(1-2):121-7. PubMed ID: 12604045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-circulating sterically stabilized liposomes in the treatment of infections.
    Bakker-Woudenberg IA; Schiffelers RM; Storm G; Becker MJ; Guo L
    Methods Enzymol; 2005; 391():228-60. PubMed ID: 15721385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic efficacy of liposomal gentamicin in clinically relevant rat models.
    Schiffelers RM; Storm G; Bakker-Woudenberg IA
    Int J Pharm; 2001 Feb; 214(1-2):103-5. PubMed ID: 11282246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of fosfomycin-gentamicin, fosfomycin-ceftazidime, fosfomycin-imipenem and ceftazidime-gentamicin combinations against ceftazidime-resistant Pseudomonas aeruginosa.
    Pruekprasert P; Tunyapanit W
    Southeast Asian J Trop Med Public Health; 2005 Sep; 36(5):1239-42. PubMed ID: 16438151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial activity of liposomal gentamicin against Pseudomonas aeruginosa: a time-kill study.
    Rukholm G; Mugabe C; Azghani AO; Omri A
    Int J Antimicrob Agents; 2006 Mar; 27(3):247-52. PubMed ID: 16472992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved efficacy of ciprofloxacin administered in polyethylene glycol-coated liposomes for treatment of Klebsiella pneumoniae pneumonia in rats.
    Bakker-Woudenberg IA; ten Kate MT; Guo L; Working P; Mouton JW
    Antimicrob Agents Chemother; 2001 May; 45(5):1487-92. PubMed ID: 11302815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy of ciprofloxacin, ceftazidime and gentamicin, given alone or in combination, in a model of experimental septicemia due to Klebsiella pneumoniae in neutropenic mice.
    Trautmann M; Brückner O; Marre R; Hahn H
    Infection; 1988; 16(1):49-53. PubMed ID: 3283038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Klebsiella pneumoniae infection in immunosuppressed mice treated with gentamicin (author's transl)].
    Fauchère JL; Berche P; Véron M; Kreis H; Crosnier J
    Ann Microbiol (Paris); 1978; 129(4):433-46. PubMed ID: 358887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the duration of infection on the activity of ceftazidime, gentamicin and ciprofloxacin in Klebsiella pneumoniae pneumonia and septicemia in leukopenic rats.
    Roosendaal R; Bakker-Woudenberg IA; van den Berghe-van Raffe M; Vink-van den Berg JC; Michel MF
    Eur J Clin Microbiol Infect Dis; 1991 Dec; 10(12):1019-25. PubMed ID: 1839380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the dosage schedule on the efficacy of ceftazidime, gentamicin and ciprofloxacin in Klebsiella pneumoniae pneumonia and septicemia in leukopenic rats.
    Roosendaal R; Bakker-Woudenberg IA; van den Berghe-van Raffe M; Vink-van den Berg JC; Michel BM
    Eur J Clin Microbiol Infect Dis; 1989 Oct; 8(10):878-87. PubMed ID: 2512132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Klebsiella pneumoniae: epidemiology and analysis of risk factors for infections caused by resistant strains.
    Li J; Ma Y; Wang Z; Yu X
    Chin Med J (Engl); 2002 Aug; 115(8):1158-62. PubMed ID: 12215282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. R-factor mediated gentamicin resistance in "Klebsiella aerogenes". A new problem in nosocomial infection.
    Casewell MW
    Quad Sclavo Diagn; 1979 Jun; 15 Suppl 1():419-33. PubMed ID: 400250
    [No Abstract]   [Full Text] [Related]  

  • 16. Disposition of liposomal gentamicin following intrabronchial administration in rabbits.
    Demaeyer P; Akodad EM; Gravet E; Schietecat P; Van Vooren JP; Drowart A; Yernault JC; Legros FJ
    J Microencapsul; 1993; 10(1):77-88. PubMed ID: 8445509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposome-mediated gentamicin delivery: development and activity against resistant strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients.
    Mugabe C; Azghani AO; Omri A
    J Antimicrob Chemother; 2005 Feb; 55(2):269-71. PubMed ID: 15590716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmid mediated antibiotic resistance in Klebsiella pneumoniae.
    Misra R; Kumar M; Menon PK; Ohri VC
    Indian J Pathol Microbiol; 2001 Oct; 44(4):427-9. PubMed ID: 12035355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbapenem-resistant Klebsiella pneumoniae endocarditis in a young adult. Successful treatment with gentamicin and colistin.
    Benenson S; Navon-Venezia S; Carmeli Y; Adler A; Strahilevitz J; Moses AE; Block C
    Int J Infect Dis; 2009 Sep; 13(5):e295-8. PubMed ID: 19329345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sputum antibiotic concentrations: implications for treatment of cystic fibrosis lung infection.
    Moriarty TF; McElnay JC; Elborn JS; Tunney MM
    Pediatr Pulmonol; 2007 Nov; 42(11):1008-17. PubMed ID: 17902147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.